Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Emma Rose 2025 Nov 22, 00:00

Citadel Securities' Rubner: S&P 500's 'Healthy' Pullback Sets Stage for Year-End Rally

Sophia Claire 2025 Nov 22, 00:00

Ray Dalio: Why You Shouldn't Abandon AI Despite Bubble Concerns

Emma Rose 2025 Nov 21, 00:00

US Nonfarm Payrolls: September's Delayed Report and Fed Rate Hike Speculation

Ava Grace 2025 Nov 21, 00:00

US Repo Market Liquidity Concerns Linger Despite Fed Easing

Frances Wang 2025 Nov 20, 16:00

AI stock analysis: BBAI stock slides 5% today, what happened to BigBear.ai?

Ghko B 2025 Nov 20, 16:00

What moved META stock today: Should You Buy the Dip on Meta Stock?

Frances Wang 2025 Nov 20, 16:00

Gold price XAUUSD analysis: XAU/USD remains neutral, what’s next?

Ghko B 2025 Nov 19, 16:00

Best AI Stocks to Buy 2026: CoreWeave (CRWV) Stock, Nvidia (NVDA), AVGO

Frances Wang 2025 Nov 19, 16:00

XRP price forecast: XRP price keeps falling, is XRP expected to go up?

Frances Wang 2025 Nov 18, 16:00

BTC/USD prediction: Bitcoin dips below $92K, will bitcoin bounce back?

Latest news

Show more
Emma Rose 2025 Nov 23, 03:10

Crypto Lending Markets Q3 2025 Analysis: A Deep Dive

Sophia Claire 2025 Nov 23, 01:50

Bitcoin Market Correction: Defensive Trading Strategies Amidst Weakness

Sophia Claire 2025 Nov 23, 01:10

BlackRock: Bitcoin Payment Use Still Speculative, Stablecoins Scaling Faster

Noah Lee 2025 Nov 23, 00:00

Market Review and Investment Strategy Insights - 2024

Sophia Claire 2025 Nov 22, 22:20

Bitcoin Transfer from OGs to Weak Hands: Analyzing the Market Impact

Ava Grace 2025 Nov 22, 20:50

Cardano Network Split Sparks FBI Investigation After AI-Fueled Glitch

Noah Lee 2025 Nov 22, 16:50

Coinbase Initiates Large Fund Migration: A Routine Security Measure

Sophia Claire 2025 Nov 22, 14:40

Market Review and Week Ahead Outlook: Gold, Oil, Stocks & Crypto in Focus

Info

Spread

0.29

Spread (%)

0.6300 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

94153580544

Shares Outstanding

2035753027

Earnings Date (Next)

2001-08-07

Div Yield

2025-11-03

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.054

EPS

2.97

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 20, 16:00

What Are Privacy Coins: Top 3 Privacy Coins, Do Privacy Coins Have a Future?

Ghko B 2025 Nov 20, 16:00

CFD Trading Explained: Understanding the Basics and Benefits of CFD

Ghko B 2025 Nov 20, 16:00

10 Best Ways to trade Cryptos as Beginner: How to Make Money with Cryptos?

Trustpilot